Abstract:Pit1 null (Snell dwarf) and Proph1 null (Ames dwarf) mutant mice lack GH, PRL and TSH. Snell and Ames dwarf mice also exhibit reduced IGF-I, resistance to cancer and a longer lifespan than control mice. Endogenous glucose production during fasting is reduced in Snell dwarf mice compared to fasting control mice. In view of cancer cell dependence on glucose for energy, low endogenous glucose production may provide Snell dwarf mice with resistance to cancer. We investigated whether endogenous glucose production is lower in Snell dwarf mice during feeding. Inhibition of endogenous glucose production by glucose injection was enhanced in 12 to 14 month-old female Snell dwarf mice. Thus, we hypothesize that lower endogenous glucose production during feeding and fasting reduces cancer cell glucose utilization providing Snell dwarf mice with resistance to cancer. The elevation of circulating adiponectin, a hormone produced by adipose tissue, may contribute to the suppression of endogenous glucose production in 12 to 14 month-old Snell dwarf mice. We compared the incidence of cancer at time of death between old Snell dwarf and control mice. Only 18% of old Snell dwarf mice had malignant lesions at the time of death compared to 82% of control mice. The median ages at death for old Snell dwarf and control mice were 33 and 26 months, respectively. By contrast, previous studies showed a high incidence of cancer in old Ames dwarf mice at the time of death. Hence, resistance to cancer in old Snell dwarf mice may be mediated by neuroendocrine factors that reduce glucose utilization besides elevated adiponectin, reduced IGF-I and a lack of GH, PRL and TSH, seen in both Snell and Ames dwarf mice. Proteomics analysis of pituitary secretions from Snell dwarf mice confirmed the absence of GH and PRL, the secretion of ACTH and elevated secretion of Chromogranin B and Secretogranin II. Radioimmune assays confirmed that circulating Chromogranin B and Secretogranin II were elevated in 12 to 14 month-old Snell dwarf mice. In summary, our results in Snell dwarf mice suggest that the pituitary gland and adipose tissue are part of a neuroendocrine loop that lowers the risk of cancer during aging by reducing the availability of glucose. Published by Elsevier Inc.

Thyroxine Modifies the Effects of Growth Hormone in Ames Dwarf Mice

Long‐lived hypopituitary Ames dwarf mice are resistant to the detrimental effects of high‐fat diet on metabolic function and energy expenditure

The Effect of Calorie Restriction on Insulin Signaling in Skeletal Muscle and Adipose Tissue of Ames Dwarf Mice

Growth hormone receptor gene disruption in mature‐adult mice improves male insulin sensitivity and extends female lifespan

Primordial follicle reserve, DNA damage and macrophage infiltration in the ovaries of the long-living Ames dwarf mice

Isolating the Direct Effects of Growth Hormone on Lifespan and Metabolism

The contribution of visceral fat to improved insulin signaling in Ames dwarf mice.

Muscle-dependent regulation of adipose tissue function in long-lived growth hormone-mutant mice

Assessment of the Primary Adrenal Cortical and Pancreatic Hormone Basal Levels in Relation to Plasma Glucose and Age in the Unstressed Ames Dwarf Mouse

Insulin sensitivity in long-lived growth hormone-releasing hormone knockout mice

Gene and transcript expression patterns, coupled with isoform switching and long non-coding RNA dynamics in adipose tissue, underlie the longevity of Ames dwarf mice

Roles of Growth Hormone-Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence

Impact of visceral adipose tissue on longevity and metabolic health: a comparative study of gene expression in perirenal and epididymal fat of Ames dwarf mice

Growth Hormone and Aging: New Findings

Physiological and metabolic characteristics of novel double‐mutant female mice with targeted disruption of both growth hormone‐releasing hormone and growth hormone receptor

Neuroendocrine Inhibition of Glucose Production and Resistance to Cancer in Dwarf Mice

Growth hormone‐releasing hormone deficiency confers extended lifespan and metabolic resilience during high‐fat feeding in mid and late life

Cell non-autonomous effect of hepatic growth differentiation factor 15 on the thyroid gland

Elevated circulating glucose increases the risk of cancer and reduces the effectiveness of medical treatment in cancer patients

Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production